Chronic non-suppurative otitis media

Summary

Chronic non-suppurative otitis media (MONDO:0021206) is a disease. A subtype of non-suppurative otitis media — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	chronic non-suppurative otitis media
Mondo ID	MONDO:0021206
SNOMED CT	232254004
UMLS	C0395869
MedGen	583104
Is cancer (heuristic)	no

Also known as: non-suppurative otitis media, chronic

Disease family

This is a subtype of non-suppurative otitis media. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › auditory system disorder › middle ear disorder › otitis media › non-suppurative otitis media › chronic non-suppurative otitis media

Related subtypes (2): acute transudative otitis media, serous otitis media

Subtypes (2): serous glue ear, otitis media with effusion

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.